Chrys Manos, OD
Optometrist · Las Vegas, NVNPI 1376641753
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.3% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Among optometrist clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 127 payments — averaging $40.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$1K
- AbbVie$661
- Alcon$650
- Optos, Inc.$571
- LKC Technologies, Inc.$379
- Bausch & Lomb, A Division Of Bausch Health US, LLC$326
- plus $1K from 12 others
What the payments were for
- Food & beverage$4,82793%
- Entertainment$3467%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 20 | $1,199 |
| AbbVie(2 entities) | 29 | $661 |
| Alcon | 21 | $650 |
| Optos, Inc. | 5 | $571 |
| LKC Technologies, Inc. | 3 | $379 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 9 | $326 |
| Sight Sciences, Inc. | 4 | $307 |
| Maculogix, Inc. | 2 | $290 |
| Tarsus Pharmaceuticals, Inc. | 8 | $204 |
| Shire North American Group Inc | 2 | $134 |
| Bausch & Lomb Americas Inc. | 6 | $91 |
| ABB Con-cise Optical Group LLC | 2 | $87 |
| Novartis | 4 | $60 |
| Oyster Point Pharma, Inc. | 4 | $60 |
| Sun Pharmaceutical Industries Inc. | 3 | $54 |
| Johnson & Johnson Vision Care, Inc. | 3 | $52 |
| Alcon Research LLC | 1 | $31 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PANORAMIC OPHTHALMOSCOPE$562
- MyDay Contact Lens$557
- OCT OPHTHALMOSCOPE$448
- AdaptDx$290
- NFC-700$281
- P200DTx$267
- P200T$267
- P200TE$267
- P200TxE$267
- TOTAL30$150
- TEARCARE SYSTEM$126
- RESTASIS$125
- ULTRA$124
- Precision7$124
- VUITY$124
- XIIDRA$122
- XDEMVY$120
- RESTASIS MULTIDOSE$107
- Clariti Contact Lens$106
- TearCare SmartLid$104
How this compares
$5,173 in reported general payments places this provider in the 90th percentile of 494 optometrist providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XdemvyLotilaner | 23 | $44,386 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Tarsus Pharmaceuticals, Inc.Xdemvy | $204 | $44,38623 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 494 optometrist providers in Nevada.
Other optometrist in Las Vegas
- Eric BrookerLas Vegas$53K
- My VuongLas Vegas$47K
- Chen YoungLas Vegas$46K
- Harlan KopolowLas Vegas$36K
- Jenny WongLas Vegas$34K
- Adam SchwartzLas Vegas$26K
- Lawrence WangLas Vegas$12K
- Brian MillerLas Vegas$11K
- Mark MillerLas Vegas$8K
- Victoria MarLas Vegas$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.